MedPath

To check efficacy of wundschutzgel in sunbur

Phase 4
Conditions
Health Condition 1: T231- Burn of first degree of wrist andhand
Registration Number
CTRI/2022/09/045569
Lead Sponsor
TRIN GmbH
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Age from 18 to 65 years

2.If female with childbearing potential, must be willing to practice an acceptable form of birth control for the duration of the study.

3.Subjects that are able to give written informed consent in a manner approved by the institutional ethics committee and comply with the requirements of the study.

4.Subjects willing to avoid participation in any other interventional clinical trial for the duration of the study.

Exclusion Criteria

1.Females that are pregnant, breast feeding, or planning to get pregnant during the study.

2.Patients that have participated in any other interventional clinical trial in the previous 30 days.

3.Patients with known sensitivity to any of the constituents of the investigational product.

4.Any person suffering from heavily bleeding or weeping wound.

Study & Design

Study Type
PMS
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction in Sunburn measured as change in VAS ScoreTimepoint: Baseline (day 0) and Day 5
Secondary Outcome Measures
NameTimeMethod
Change in skin ElasticityTimepoint: Baseline (day 0) and Day 5;Change in skin ErythemaTimepoint: Baseline (day 0) and Day 5;QOL changes to be measured as DLQITimepoint: Baseline (day 0) and Day 5
© Copyright 2025. All Rights Reserved by MedPath